Skip to main content
Clinical Trials/IRCT20220723055527N1
IRCT20220723055527N1
Completed
Phase 1

A clinical trial to compare the effectiveness of the total neoadjuvant therapy with standard approach in rectal adenocarcinoma patients

Mashhad University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Mashhad University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with rectal adenocarcinoma based on pathological diagnosis
  • The zero to two level of Eastern Cooperative Oncology Group (ECOG)
  • Healthy functioning bone marrow
  • Healthy functioning liver
  • Healthy functioning kidneys

Exclusion Criteria

  • Having simultaneous adenocarcinoma in other areas of the colon
  • Having metastasis
  • History of previous malignancy
  • History of chemotherapy
  • History of pelvic radiotherapy
  • Having inflammatory intestinal disease
  • Having bilateral hip prosthesis
  • Having allergic to 5\-fluorouracil and its other derivatives
  • Having allergic to oxaliplatin

Outcomes

Primary Outcomes

Not specified

Similar Trials